Best Academic Researcher Award
Vikrant Verma — Subharti University, India
Vikrant Verma is a pharmaceutical researcher and academic affiliated with Subharti University in Meerut, Uttar Pradesh, India. His documented research activities cover pharmaceutical chemistry, pharmacology, drug formulation, analytical methods, medicinal chemistry, and pharmaceutical and biomedical applications. The available ORCID record identifies an academic appointment at the Kharvel Subharti College of Pharmacy and records research works across multiple publication years.[1]
Abstract
Vikrant Verma’s documented academic profile reflects research activity within pharmaceutical chemistry and related biomedical disciplines. His recorded publications address medicinal compounds, pharmaceutical formulations, analytical procedures, pharmacological mechanisms, and emerging therapeutic technologies. The ORCID record lists 25 works, including journal articles and book chapters, while the supplied profile records 20 documents, 71 citations, and an h-index of 4. Recent works include studies of drug discovery, cardiovascular therapeutics, herbal compounds, radiopharmaceuticals, and wearable healthcare technologies. [1]
Keywords
Vikrant Verma, pharmaceutical chemistry, medicinal chemistry, pharmacology, drug formulation, pharmaceutical analysis, drug discovery, therapeutic research, Subharti University, academic researcher, pharmaceutical research.
Introduction
Pharmaceutical chemistry integrates chemical principles with the discovery, characterization, formulation, and evaluation of compounds relevant to medicine. Verma’s documented publication record demonstrates involvement in this broad research environment through original studies and review-oriented contributions. His work includes conventional pharmaceutical formulation and analytical method development alongside research addressing contemporary pharmacological and biomedical questions. The range of recorded topics provides a basis for describing his academic activity across interconnected areas of pharmaceutical science. [2]
Research Profile
The ORCID record identifies Vikrant Verma with Swami Vivekanand Subharti University, Meerut, and an academic role at the Kharvel Subharti College of Pharmacy. His listed works extend from earlier pharmaceutical and phytochemical research to recent investigations and reviews in pharmacology and drug development. Examples include research on quinolone derivatives, piracetam derivatives, fluconazole analysis, sustained-release formulations, and herbal interventions. More recent publications address artificial intelligence in drug discovery, endothelial dysfunction, quercetin, radiopharmaceuticals, and wearable devices. [3]
Research Contributions
The publication record indicates contributions spanning pharmaceutical formulation, medicinal chemistry, analytical methodology, pharmacological review, and translational biomedical subjects. His documented studies include sustained-release formulations involving reserpine and polythiazide, method development involving antihypertensive agents, and synthesis and evaluation of heterocyclic compounds. Other publications examine herbal extracts, traditional medicines, and therapeutic mechanisms relevant to contemporary pharmaceutical research. Together, these works illustrate a research profile connecting laboratory-oriented pharmaceutical chemistry with broader drug-development and therapeutic themes. [4]
Publications
Selected recent publications include “Mechanistic pharmacology of TCM-derived bioactive compounds in Alzheimer’s disease,” published in Pharmacological Research – Modern Chinese Medicine, and “Mechanistic Insights, Structure-activity Relationships, and Safety Profile of Mitragyna speciosa Alkaloids.” Other recorded works include “Theranostic applications of PSMA-targeted radiopharmaceuticals,” “Quercetin and the gut-brain axis,” and “Artificial intelligence and machine learning in drug discovery.” The record also contains earlier articles concerning fluconazole analysis, piracetam derivatives, thiadiazole derivatives, and phytotoxin characterization. [5]
Research Impact
The supplied bibliometric profile reports 20 documents, 71 citations, and an h-index of 4. These indicators provide quantitative information about the documented publication and citation record associated with the researcher. Citation counts and h-index values can change as indexing databases update their records and therefore represent measurements at a particular point in time. The ORCID record further provides a structured overview of the researcher’s works and their associated publication metadata.[4]
Award Suitability
The Best Academic Researcher Award profile can be supported by documented academic affiliation, a defined pharmaceutical chemistry subject area, and a record of scholarly publications. Verma’s ORCID record demonstrates continued publication activity across pharmaceutical and biomedical research topics, including several works published during 2025 and 2026. His Scopus identifier and supplied bibliometric indicators provide additional mechanisms for documenting the research record. The evidence presented here can therefore serve as a factual academic profile for consideration within the World Top Scientist Awards event.[4]
Conclusion
Vikrant Verma’s documented research portfolio encompasses multiple areas within pharmaceutical chemistry and related biomedical science. His publications demonstrate activity in formulation, medicinal chemistry, pharmacological research, analytical methods, and emerging therapeutic applications. The available record combines bibliometric information with identifiable publications and persistent researcher identifiers. These documented elements provide a structured basis for presenting his academic research profile in connection with the Best Academic Researcher Award.[4]
External Links
References
- ORCID. (2026). Vikrant Verma: ORCID record and works. ORCID.
https://orcid.org/0000-0002-1994-9641
- Verma, V., & Kumar, D. (2026). Mechanistic insights, structure-activity relationships, and safety profile of Mitragyna speciosa alkaloids. Current Bioactive Compounds. DOI: 10.2174/0115734072492003260811045218.
https://doi.org/10.2174/0115734072492003260811045218
- Kumar, A., & Verma, V. (2026). Mechanistic pharmacology of TCM-derived bioactive compounds in Alzheimer’s disease: Molecular targets, standardization, and translational insights. Pharmacological Research – Modern Chinese Medicine. DOI: 10.1016/j.prmcm.2026.100831.
https://doi.org/10.1016/j.prmcm.2026.100831
- Verma, V., & Kumar, D. (2026). Theranostic applications of PSMA-targeted radiopharmaceuticals: From molecular design to clinical translation and emerging paradigms. Current Radiopharmaceuticals. DOI: 10.1016/j.craph.2026.100054.
https://doi.org/10.1016/j.craph.2026.100054
- Verma, V., & Kumar, D. (2026). Quercetin and the gut-brain axis: Microbiome modulation, neuroprotection, and therapeutic implications. AIMS Molecular Science, 2026. DOI: 10.3934/molsci.2026012.
https://doi.org/10.3934/molsci.2026012